Riskpilot← Back to searchSign inGet full accessNellphoria AB
ABActiveOrg 5592435027Upplandsgatan 39Beauty care and other beauty treatment activities · NACE 9622Est. 20201 employees
Revenue 2025
SEK 1,9M
-2% vs 2024
EBITDA margin
6.6%
+335% vs 2024
Equity ratio
44.7%
Financial strength
Net profit 2025
SEK 56K
+1868% vs 2024
| Revenue | SEK 1,9M | -2% |
| EBITDA | SEK 128K | +335% |
| Net profit | SEK 56K | +1868% |
| Total assets | SEK 764K | -8% |
| Equity | SEK 342K | +20% |
| Employees | 1 | — |
Legal name
Nellphoria AB
Org number
5592435027
Legal form
Aktiebolag
NACE code
9622 · Beauty care and other beauty treatment activities
Founded
19 februari 2020
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall tillhandahålla uthyrning av leg sjuksköterska till hälsa- och sjukvården som främst innebär att arbeta som underleverantör till etablerade bemanningsföretag. Verksamheten tillhandahåller även injektionsbehandlingar i form av fillers- och botoxprodukter och därmed förenlig verksamhet.
Address
Upplandsgatan 39
Email
agnes.bergenby@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 735 | 2 014 | 2 047 | 1 971 | 1 924 |
| Staff expenses | — | −790 | −821 | −594 | −435 |
| EBITDA | 84 | 106 | 48 | 29 | 128 |
| Depreciation & amort. | −12 | −12 | −2 | −37 | −41 |
| EBIT | 72 | 94 | 46 | −8 | 87 |
| Net financials | −3 | −3 | −1 | −1 | −1 |
| Profit before tax | 61 | 91 | 45 | 6 | 71 |
| Tax | −16 | −10 | −24 | −4 | −15 |
| Net profit | 45 | 81 | 21 | 3 | 56 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 352 | 377 | 476 | 833 | 764 |
| Equity | 181 | 262 | 283 | 286 | 342 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 121 | 65 | 143 | 512 | 372 |
| Total debt | 121 | 65 | 143 | 512 | 372 |
EBITDA margin
6.6%
This company
15.8%
Market median
-58% vs market
20212025
Equity ratio
44.7%
This company
38.2%
Market median
+17% vs market
20212025
Return on equity
16.4%
This company
18.4%
Market median
+11% vs market
20212025
Net profit margin
2.9%
This company
8.1%
Market median
-64% vs market
20212025
Asset turnover
2.52×
This company
1.12×
Market median
+125% vs market
20212025
Debt / equity
1.24×
This company
0.62×
Market median
-100% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (3) | ||
| Deputy Board Member | 2020 – 2022 | |
| Board of Directors | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Nellphoria AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Henrik Kristoffer Svensson | Deputy Board Member | 0 companies |
| Agnes-Cecilia Nell Bergenby | Board of Directors | 0 companies |
| Nina Marika Wodzinski | Board of Directors | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |
| Jens Fredrik Bergenby | Deputy Board Member | 0 companies |